Loading people...
Cindy Cole is a Partner at Digitalis Ventures based in Gainesville, Florida. She holds a Doctor of Veterinary Medicine and a doctorate in cardiovascular pharmacology from the University of Florida, where she serves as an Associate Clinical Professor and Director of the Racing Laboratory. Prior to venture investing, Cole held senior management positions across the animal health sector, including serving as Global Head of Clinical Development at Novartis Animal Health and working in research at IDEXX Laboratories and Mars Petcare. At Digitalis Ventures, which recently closed a $200 million fourth fund, she evaluates technical investments and is associated with portfolio companies such as PetMedix and Scout Bio. Her current focus centers on leveraging her academic and corporate veterinary pharmacology expertise to identify early-stage biotechnology startups operating at the intersection of human and animal health.
Cindy Cole serves as a distinguished Partner at Digitalis Ventures, a leading venture capital firm dedicated to investing in the future of health. As a key member of the investment team, Cindy Cole plays a pivotal role in identifying and nurturing companies that are poised to make a significant impact across the health technology and biotechnology landscapes. Her strategic vision and deep industry knowledge are instrumental in guiding Digitalis Ventures' investment thesis.
At Digitalis Ventures, Cindy Cole's investment focus spans a broad range of innovative sectors within health. She is particularly interested in early-stage companies leveraging cutting-edge technologies such as artificial intelligence, machine learning, and advanced data analytics to solve complex healthcare challenges. Her portfolio interests include digital health platforms, novel therapeutics, medical devices, diagnostics, and enterprise software solutions designed to improve patient outcomes, enhance operational efficiency, and reduce healthcare costs. Cindy Cole actively seeks out founders with bold ideas and the potential to disrupt traditional healthcare models.
Cindy Cole brings a wealth of experience to her role at Digitalis Ventures. Her career background is marked by a strong commitment to fostering innovation and growth within the life sciences and technology sectors. Prior to joining Digitalis Ventures, Cindy Cole honed her expertise through various roles that provided her with a comprehensive understanding of market dynamics, technological advancements, and the operational intricacies of scaling high-growth companies. This diverse background equips her with a unique perspective, enabling her to provide invaluable strategic guidance and mentorship to portfolio companies.
While specific notable investments are often confidential, Cindy Cole has been instrumental in identifying and supporting companies that have gone on to achieve significant milestones and market recognition. Her approach involves rigorous due diligence, a keen eye for market opportunity, and a collaborative partnership with entrepreneurs. Cindy Cole is known for her hands-on approach, working closely with founders to navigate challenges, accelerate product development, and build robust business models. Her dedication to advancing healthcare through strategic investment makes her a respected figure in the venture capital community. Cindy Cole continues to drive Digitalis Ventures' mission to back the next generation of healthcare pioneers.
Cindy Cole is a Partner at Digitalis Ventures, a venture capital firm. She is an investor focused on early-stage health technology and biotechnology companies.
Cindy Cole invests in early-stage health technology and biotechnology companies. Her focus areas include digital health, AI in healthcare, novel therapeutics, medical devices, diagnostics, and enterprise software solutions for healthcare.
Cindy Cole works as a Partner at Digitalis Ventures, a venture capital firm specializing in health and life sciences investments.
